At a time when opioid overdoses and deaths are at an all-time high in our country, understanding and using the antidote is more important than ever. NADCP’s National Drug Court Institute (NDCI) is pleased to announce the release of a new fact sheet: “Naloxone: Overview and Considerations for Drug Court Programs.” The fact sheet accompanies a new, online naloxone training course for treatment court professionals, clients, and stakeholders on the safe use of naloxone. Both resources are available here.
Naloxone is a prescription medication that reverses the effects of an opioid overdose and saves lives. It has been safely used by both medical professionals and lay people for decades, and many localities are implementing naloxone education and distribution programs to help fight the opioid epidemic. Some states have even issued standing prescriptions so that anyone can pick up naloxone (sold under the brand names Narcan and Evzio) at their local pharmacy. The goal of these programs is to help people prevent, recognize, and intervene in overdoses to prevent the further loss of life to this epidemic. Other goals, such as decreasing or stopping drug use, can only be achieved if the person is alive.
Drug court professionals may have questions about naloxone, such as “How does the medication work?”; “Should all drug court clients be trained to use and given naloxone?”; “How do we pay for it?”; and “Are training resources available?”
Our new fact sheet answers all of the above questions and more. In addition, NDCI has a series of fact sheets on critical topics facing treatment courts. Download the new naloxone fact sheet and browse fact sheets on other subjects here.